Atorvastatin News and Research

RSS
Common anti-cholesterol drugs show promise for reducing Alzheimer's disease risk

Common anti-cholesterol drugs show promise for reducing Alzheimer's disease risk

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

High-intensity statin treatments increase survival rates in patients with cardiovascular disease

Research shows how mitochondrial targeting antioxidants could help treat osteoarthritis

Research shows how mitochondrial targeting antioxidants could help treat osteoarthritis

New controlled drug release system could revolutionize success rate of vascular bypasses

New controlled drug release system could revolutionize success rate of vascular bypasses

Women less likely to stick to cardiac rehabilitation program than men, study finds

Women less likely to stick to cardiac rehabilitation program than men, study finds

Evolocumab could be more effective than ezetimibe in lowering cholesterol in statin-intolerant patients

Evolocumab could be more effective than ezetimibe in lowering cholesterol in statin-intolerant patients

Researchers compare lipid-lowering efficacy for two nonstatin therapies in statin-intolerant patients

Researchers compare lipid-lowering efficacy for two nonstatin therapies in statin-intolerant patients

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Amgen announces approval of cholesterol-lowering medication Repatha (evolocumab) Injection in Japan

Medlab granted ethics approval to begin human trials using nanotechnology delivery platform

Medlab granted ethics approval to begin human trials using nanotechnology delivery platform

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

Resverlogix announces formation of international Clinical Steering Committee for RVX-208 "apabetalone" Phase 3 trial

Generic heart disease drugs show promise in patients affected by Ebola virus

Generic heart disease drugs show promise in patients affected by Ebola virus

Statins benefit patients undergoing major lung resection, lower major complications

Statins benefit patients undergoing major lung resection, lower major complications

New study predicts outcomes of CV patients using polypill intervention

New study predicts outcomes of CV patients using polypill intervention

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Janssen, Gilead to jointly develop darunavir-based, single-tablet regimen for HIV treatment

Australian Prescriber publishes top 10 subsidised drugs in Australia

Australian Prescriber publishes top 10 subsidised drugs in Australia

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

Commonly used lipid-lowering drug protects against cerebral ischemia/reperfusion injury

Commonly used lipid-lowering drug protects against cerebral ischemia/reperfusion injury

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Controlling low-density lipoprotein-cholesterol levels: an interview with Jay Edelberg, M.D., Sanofi and Bill Sasiela, Ph.D., Regeneron

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease